Indukern   Report issue

For profit Phase 2
Founded: Barcelona Spain (1962)
Status: No NME R&D (1962)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (3)

Key: Indukern (0) Acquired (3)

acadesine (arasine) (2 trials)

ath008 (1 trial)

nt-ko-003 (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 4
  • # of Trial APIs: 3